Neuralstem secures patent for stem cell transplantation

09/9/2009 | American City Business Journals

Neuralstem has received a patent for the production and transplantation of neural stem cells for the treatment of nervous system disorders. The company is awaiting a decision from the FDA on its request to start human trials of its stem cell therapies for amyotrophic lateral sclerosis, or Lou Gehrig's disease.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI